Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infection-Reference-Cited by-同舟云学术

Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infection

Published:2017-09-10 Issue:14 Volume:31 Page:1935-1943
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Gatanaga Hiroyuki,Brumme Zabrina L.,Adland Emily,Reyes-Terán Gustavo,Avila-Rios Santiago,Mejía-Villatoro Carlos R.,Hayashida Tsunefusa,Chikata Takayuki,Van Tran Giang,Van Nguyen Kinh,Meza Rita I.,Palou Elsa Y.,Valenzuela-Ponce Humberto,Pascale Juan M.,Porras-Cortés Guillermo,Manzanero Marvin,Lee Guinevere Q.,Martin Jeffrey N.,Carrington Mary N.,John Mina,Mallal Simon,Poon Art F.Y.,Goulder Philip,Takiguchi Masafumi,Oka Shinichi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference40 articles.

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators;Palella;N Engl J Med,1998

2. The survival benefits of AIDS treatment in the United States;Walensky;J Infect Dis,2006

3. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic;Montaner;Lancet,2006

4. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial;Grinsztejn;Lancet Infect Dis,2014

5. Antiretroviral therapy for the prevention of HIV-1 transmission;Cohen;N Engl J Med,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High Level of Pre-Treatment HIV-1 Drug Resistance and Its Association with HLA Class I-Mediated Restriction in the Pumwani Sex Worker Cohort;Viruses;2022-01-28

2. Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in Uganda;AIDS;2021-02-23

3. What Will Happen to Biomedical Research in Low-and-Middle Income Countries in the PostCOVID-19 World?;Current Tropical Medicine Reports;2021-01-04

4. Comment on: Tenofovir DF/emtricitabine/rilpivirine as HIV post-exposure prophylaxis: results from a multicentre prospective study;Journal of Antimicrobial Chemotherapy;2019-07-06

5. Antiretroviral agents in pre-exposure prophylaxis: emerging and advanced trends in HIV prevention;Journal of Pharmacy and Pharmacology;2019-05-29